* Bioventus Inc BVS.OQ reported quarterly adjusted
earnings of
14 cents per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for breakeven
results per share.
* Revenue fell 2.3% to $137.07 million from a year ago;
analysts
expected $129.23 million.
* Bioventus Inc's reported EPS for the quarter was a loss
of 6
cents.
* The mean earnings estimate of analysts had risen by
about 100%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* Bioventus Inc shares had risen by 17.6% this quarter and
gained 30.3% so far this year.
* The company reported a quarterly loss of $3.68 million.
* Wall Street's median 12-month price target for Bioventus
Inc is
$3.50
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 8 at 01:34 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 0.00 0.14 Beat
Mar. 31 2023 -0.15 -0.26 Missed
Dec. 31 2022 0.05 -0.06 Missed
Sep. 30 2022 0.12 0.08 Missed